title: Pneumococcal meningitis in community is frequent after craniocerebral trauma and in alcohol abusers.
abstract: Aim of this short communication was to assess risk factors and outcome of community acquired pneumococcal meningitis and compare it to all cases of community acquired meningitis. Univariate analysis was used for comparison of 68 pneumococcal to 201 CBM within a Slovak nationwide database of CBM. Significant risk factors for pneumococcal meningitis were previous craniocerebral trauma within 7 days (39.7% vs. 14.9%, p=0.00002), splenectomy (10.3% vs. 3.5%, p=0.03) and alcohol abuse (36.8% vs. 15.4%, p=0.0001). Concerning outcome, mortality was similar (8,8% and 12,4%, NS), proportion of those with neurologic sequellae after CBM due to Str. pneumoniae was insignificantly higher (20.6% vs. 15.4%, NS) in comparison to all CBM. All but 2 strains Str. pneumoniae were susceptible to penicillin and macrolides (3.3% resistance).
authors.affiliation: St. Elizabeth University College, Tropical Projects, Gordim, Nyamlel, Slovakia.
authors.forename: J
authors.initials: J
authors.lastname: Benca
authors.forename: A
authors.initials: A
authors.lastname: Lesnakova
authors.forename: K
authors.initials: K
authors.lastname: Holeckova
authors.forename: A
authors.initials: A
authors.lastname: Ondrusova
authors.forename: O
authors.initials: O
authors.lastname: Wiczmandyova
authors.forename: V
authors.initials: V
authors.lastname: Sladecko
authors.forename: F
authors.initials: F
authors.lastname: Hvizdak
authors.forename: M
authors.initials: M
authors.lastname: Bartkovjak
authors.forename: S
authors.initials: S
authors.lastname: Seckova
authors.forename: M
authors.initials: M
authors.lastname: Taziarova
authors.forename: M
authors.initials: M
authors.lastname: Huttova
authors.forename: M
authors.initials: M
authors.lastname: Bielova
authors.forename: R
authors.initials: R
authors.lastname: Luzica
authors.forename: M
authors.initials: M
authors.lastname: Karvaj
authors.forename: M
authors.initials: M
authors.lastname: Kovac
authors.forename: F
authors.initials: F
authors.lastname: Bauer
authors.forename: I
authors.initials: I
authors.lastname: Sabo
authors.forename: V
authors.initials: V
authors.lastname: Svabova
authors.forename: L
authors.initials: L
authors.lastname: Findova
authors.forename: P
authors.initials: P
authors.lastname: Bukovinova
authors.forename: A
authors.initials: A
authors.lastname: Shahum
mesh_terms: D019973:Alcohol-Related Disorders / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000150:complications / Q000382:microbiology / Q000628:therapy; D006259:Craniocerebral Trauma / Q000150:complications*; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use; D008581:Meningitis / Q000150:complications* / Q000628:therapy; D008586:Meningitis, Pneumococcal / Q000150:complications* / Q000628:therapy; D017063:Outcome Assessment, Health Care; D010406:Penicillins / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D010406:Penicillins